IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,504,790 | -7.3% | 121,452 | -22.5% | 0.19% | -31.5% |
| Q3 2022 | $1,623,000 | +28.8% | 156,626 | +43.4% | 0.28% | -9.1% |
| Q2 2022 | $1,260,000 | -8.3% | 109,240 | 0.0% | 0.31% | +10.0% |
| Q1 2022 | $1,374,000 | -46.1% | 109,240 | -50.0% | 0.28% | +6.9% |
| Q4 2021 | $2,548,000 | +78.6% | 218,480 | +100.0% | 0.26% | -16.1% |
| Q3 2021 | $1,427,000 | +54.8% | 109,240 | +52.5% | 0.31% | +87.3% |
| Q2 2021 | $922,000 | +15.4% | 71,615 | +0.2% | 0.17% | +13.7% |
| Q1 2021 | $799,000 | -1.8% | 71,494 | 0.0% | 0.15% | -16.1% |
| Q4 2020 | $814,000 | +66.5% | 71,494 | +31.5% | 0.17% | +34.9% |
| Q3 2020 | $489,000 | -12.8% | 54,350 | 0.0% | 0.13% | -9.2% |
| Q2 2020 | $561,000 | +2.4% | 54,350 | 0.0% | 0.14% | -15.5% |
| Q1 2020 | $548,000 | -6.0% | 54,350 | +24.0% | 0.17% | +54.1% |
| Q4 2019 | $583,000 | -52.9% | 43,816 | -43.4% | 0.11% | -53.8% |
| Q1 2015 | $1,238,000 | – | 77,359 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |